Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
11/10/201011:00AMBusiness WireImmunoGen, Inc. Announces Webcast of Presentation at Lazard Capital Markets 7th Annual Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
11/02/20108:15AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/02/20105:30AMBusiness WireImmunoGen, Inc. Announces Presentations at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer TherapeuticsNASDAQ:IMGNImmunoGen Inc
10/29/20103:48PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:IMGNImmunoGen Inc
10/28/20103:07PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IMGNImmunoGen Inc
10/28/20103:01PMBusiness WireImmunoGen, Inc. Reports First Quarter Fiscal Year 2011 Financial ResultsNASDAQ:IMGNImmunoGen Inc
10/21/20105:30AMBusiness WireImmunoGen, Inc. Announces Conference Call to Discuss its First Quarter Fiscal Year 2011 Financial ResultsNASDAQ:IMGNImmunoGen Inc
10/19/201010:10AMBusiness WireImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor ConferencesNASDAQ:IMGNImmunoGen Inc
10/11/201011:25AMDow Jones News2nd UPDATE: Roche Cancer Drugs Show Positive ResultsNASDAQ:IMGNImmunoGen Inc
10/11/201010:17AMDow Jones NewsUPDATE: Roche Cancer Drugs Show Positive ResultsNASDAQ:IMGNImmunoGen Inc
10/11/20106:30AMDow Jones NewsImmunoGen Cuts Year Forecast, Announces Positive Study ResultsNASDAQ:IMGNImmunoGen Inc
10/11/20106:12AMDow Jones NewsUPDATE: Novartis, Immunogen To Co-Produce Cancer DrugsNASDAQ:IMGNImmunoGen Inc
10/11/20105:30AMBusiness WireImmunoGen, Inc. Announces Presentation of Encouraging Clinical Data for Lorvotuzumab Mertansine at ESMO Annual MeetingNASDAQ:IMGNImmunoGen Inc
10/11/20105:15AMBusiness WireImmunoGen, Inc. Announces Conference Call at 8:30 am ET October 11, 2010 to Discuss New Collaboration & Updated Guidance for ...NASDAQ:IMGNImmunoGen Inc
10/11/20105:15AMBusiness WireImmunoGen, Inc. Announces Updated Guidance for 2011 Fiscal YearNASDAQ:IMGNImmunoGen Inc
10/11/20103:43AMDow Jones NewsNovartis And Immunogen To Co-Produce Cancer DrugsNASDAQ:IMGNImmunoGen Inc
10/11/20102:30AMBusiness WireImmunoGen, Inc. Announces Collaboration for Rights to Use ImmunoGen’s TAP TechnologyNASDAQ:IMGNImmunoGen Inc
10/08/20101:20PMBusiness WireImmunoGen, Inc. Announces Positive Interim Results in Randomized Clinical Trial Comparing Trastuzumab-DM1 vs. Standard First-...NASDAQ:IMGNImmunoGen Inc
10/04/20109:21AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:IMGNImmunoGen Inc
10/04/20109:19AMEdgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:IMGNImmunoGen Inc
10/01/20108:18AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
10/01/20108:18AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
09/27/201012:03PMDow Jones NewsUPDATE: Seattle Genetics, Takeda Lymphoma Drug Shows SuccessNASDAQ:IMGNImmunoGen Inc
09/24/20107:01AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IMGNImmunoGen Inc
09/21/20105:30AMBusiness WireImmunoGen, Inc. Announces Start of SAR566658 Clinical TestingNASDAQ:IMGNImmunoGen Inc
09/02/20105:30AMBusiness WireImmunoGen, Inc. Announces Webcast of Presentations at Multiple Investor Conferences in SeptemberNASDAQ:IMGNImmunoGen Inc
08/27/20101:08PMEdgar (US Regulatory)Annual Report (10-K)NASDAQ:IMGNImmunoGen Inc
08/27/201010:13AMDow Jones News3rd UPDATE: Roche's Hopes For Speedy Drug Approval DashedNASDAQ:IMGNImmunoGen Inc
08/27/20105:11AMDow Jones News2nd UPDATE: Roche Hopes For Speedy Drug Approval DashedNASDAQ:IMGNImmunoGen Inc
08/27/20105:01AMBusiness WireGenentech Receives Refuse to File Letter from FDA for T-DM1NASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN